The review concluded that low dose bupivacaine for Caesarean delivery spinal anaesthesia compromised anaesthetic efficacy despite the benefit of lower maternal hypotension and nausea/vomiting. The review was well conducted and the results seem reliable; however, an arbitrary cut-off value for low dose bupivacaine means that a degree of caution is warranted when interpreting the authors' conclusions.
Authors' objectives
To compare the efficacy and adverse effects of low dose spinal bupivacaine compared with conventional dose spinal bupivacaine for elective Caesarean delivery.
Searching
MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL) and LILACS were searched to October 2008 for articles in any language published in peer-reviewed journals. Search terms were reported. Reference lists of retrieved articles and relevant journals were handsearched. The MEDLINE search was updated in December 2010.
Study selection
Randomised controlled trials (RCTs) of low dose spinal bupivacaine (≤8mg) versus conventional dose spinal bupivacaine (>8mg) in elective or semi-urgent caesarean delivery under neuraxial spinal anaesthesia were eligible for inclusion. Trials were limited to American Society of Anaesthesiologist I-II term parturients. Primary outcomes were frequency of intraoperative analgesic supplementation by any route and conversion to general anaesthesia. Secondary outcomes were maternal adverse effects, neonatal outcomes, patient satisfaction during the intraoperative period and surgical conditions as assessed by the surgeon.
The included trials studied low dose spinal bupivacaine (4mg to 8mg) versus conventional dose spinal bupivacaine (8.7mg to 12.5mg) in patients with a mean age of 24 to 37 years. Various neuraxial techniques were used. Various concomitant drugs were administered. The trials were published between 2000 and 2010 and conducted in North America, South America, Europe, Asia and Africa. The mean weight of patients ranged from 58kg to 85kg.
Two reviewers independently performed study selection. Disagreements were resolved by consensus.
Assessment of study quality
Trial quality was assessed using the Jadad scale of randomisation, blinding and withdrawals to give a score out of five. The Cochrane Handbook was used to assess trial quality on the basis of randomisation, allocation concealment, blinding, incomplete outcome data, selective reporting and other biases. Evidence for each outcome was graded according to the GRADE criteria.
The two authors performed quality assessment independently.
Data extraction
Data were extracted on primary and secondary outcomes and used to calculate relative risks (RRs), together with 95% confidence intervals (CIs).
The two authors extracted data independently. Disagreements were resolved by discussion.
Methods of synthesis
Random-effects meta-analysis was undertaken to calculate pooled relative risks and 95% CIs. Fixed-effect metaanalysis was used for one outcome. Statistical heterogeneity was assessed using the Ι² statistic. The weighted rounded
